KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Receivables (2016 - 2025)

Historic Receivables for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $1.0 billion.

  • Incyte's Receivables rose 2007.29% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 2007.29%. This contributed to the annual value of $1.0 billion for FY2025, which is 2007.29% up from last year.
  • As of Q4 2025, Incyte's Receivables stood at $1.0 billion, which was up 2007.29% from $895.9 million recorded in Q3 2025.
  • Incyte's 5-year Receivables high stood at $1.0 billion for Q4 2025, and its period low was $397.4 million during Q1 2021.
  • Over the past 5 years, Incyte's median Receivables value was $670.1 million (recorded in 2022), while the average stood at $691.1 million.
  • In the last 5 years, Incyte's Receivables skyrocketed by 5586.83% in 2022 and then tumbled by 658.51% in 2023.
  • Quarter analysis of 5 years shows Incyte's Receivables stood at $616.3 million in 2021, then increased by 4.64% to $644.9 million in 2022, then grew by 15.3% to $743.6 million in 2023, then increased by 14.74% to $853.2 million in 2024, then grew by 20.07% to $1.0 billion in 2025.
  • Its Receivables stands at $1.0 billion for Q4 2025, versus $895.9 million for Q3 2025 and $842.9 million for Q2 2025.